Preclinical antitumor activity reported for (R)-bicalutamide derivatives ISIR-9 and ISIR-11 March 18, 2011
Researchers describe protein aggregation inhibitor with potential for neurodegenerative diseases March 16, 2011
Safety and tolerability of GT-MAb 2.5-GEX seen in phase I trial in advanced/metastatic cancer March 16, 2011
Interim phase I data support safety and promising activity of namitecan in solid tumors March 15, 2011
RSS